Research Notes The Effectiveness of Controversial Multiple Sclerosis Drug

Armen Hareyan's picture

Multiple Sclerosis Drug

Cleveland Clinic-based research has found that a drug used to treat multiple sclerosis (MS), which was pulled off the market by its manufacturers a year ago because of safety concerns, is effective in treating patients with relapsing multiple sclerosis.

Researchers are reporting that when used in combination with the standard treatment of interferon beta-1a, natalizumab, the drug previously marketed under the brand name Tysabri, reduced the risk of a